⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12191508 | 1.00 | — | — | |
| SCHEMBL12191506 | 1.00 | — | — | |
| SCHEMBL12437872 | 0.87 | — | — | |
| SCHEMBL5983613 | 0.87 | — | — | |
| SCHEMBL14961820 | 0.87 | — | — | |
| SCHEMBL14961821 | 0.87 | — | — | |
| SCHEMBL6755980 | 0.84 | IDO1 (0.31) | — | |
| SCHEMBL12855376 | 0.84 | IDO1 (0.31) | — | |
| SCHEMBL7499850 | 0.76 | L3MBTL1 (0.34) | — | |
| SCHEMBL3149036 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111349111-A | Pentazocine prodrug, preparation method and application thereof | 安徽省逸欣铭医药科技有限公司 | 2020-06-30 | — | — | CN | disclosed |
| US-9717712-B2 | Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160166547-A1 | Combinations Comprising Tricyclohexadecahexaene Derivatives for Use in the Treatment of Hepatitis C Virus | BRISTOL MYERS SQUIBB CO (US) | 2016-06-16 | — | — | US | disclosed |
| EP-1535896-B1 | PROCESS FOR PRODUCING CARBONIC ESTER | ASAHI KASEI CHEMICALS CORP (JP) | 2015-10-07 | — | — | EP | disclosed |
| EP-1760085-B1 | PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES | ASAHI KASEI CHEMICALS CORP (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-8063033-B2 | Therapeutic beta-lactams | ALLERGAN, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-8044092-B2 | Therapeutic compounds | ALLERGAN, INC. (US) | 2011-10-25 | — | — | US | disclosed |
| EP-1640357-B1 | METHOD FOR PRODUCING AROMATIC CARBONATE | ASAHI KASEI CHEMICALS CORP (JP) | 2011-08-31 | — | — | EP | disclosed |
| CN-1997654-B | Process for production of alkyltin alkoxides | ASAHI CHEMICAL IND | 2011-05-11 | — | — | CN | disclosed |
| US-20100317872-A1 | THERAPEUTIC COMPOUNDS | ALLERGAN, INC. (US) | 2010-12-16 | — | — | US | disclosed |
| CN-1839112-A | Method for producing aromatic carbonate | ASAHI CHEMICAL CORP (JP) | 2006-09-27 | — | — | CN | disclosed |
| EP-1483249-B1 | PYRIMIDINE DERIVATIVES AND THEIR USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2006-09-06 | — | — | EP | disclosed |
| EP-1640357-A1 | METHOD FOR PRODUCING AROMATIC CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20050240045-A1 | Process for producing carbonic ester | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-10-27 | — | — | US | disclosed |
| CN-1675163-A | Process for producing carbonic ester | ASAHI CHEMICAL IND (JP) | 2005-09-28 | — | — | CN | disclosed |
| EP-1535896-A1 | PROCESS FOR PRODUCING CARBONIC ESTER | Asahi Kasei Chemicals Corporation (JP) | 2005-06-01 | — | — | EP | disclosed |
| US-20030089885-A1 | Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids | SENOMYX, INC. | 2003-05-15 | — | — | US | disclosed |
| WO-2002085294-A2 | USE OF LOW MOLECULAR WEIGHT ACETAL, ALCOHOL, ACYLATED ALCOHOL AND ESTER COMPOUNDS TO BLOCK OR REDUCE ODOR OF CARBOXYLIC ACIDS | SENOMYX, INC. (US) | 2002-10-31 | — | — | WO | disclosed |
| EP-1091944-A1 | 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS | Du Pont Pharmaceuticals Company (US) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000000479-A1 | 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-01-06 | — | — | WO | disclosed |